Zai Lab Ltd
ZLAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001704292
In the last 90 days, Zai Lab Ltd insiders filed 0 open-market purchases and 3 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $819.0M in total; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $235.1K in total
- 3
- 13F holdersQ2 2026, −6 vs. previous quarter
- 92
- 13F valueReported value at the end of Q2 2026
- $819.0M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $460.2M
- +15.3% year over year
- Net income, FY2025
- -$175.5M
- No comparable prior period
- Free cash flow, FY2025
- -$158.9M
- No comparable prior period
- Revenue, Q3 FY2026
- $108.2M
- −6.8% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $175.5M (38.1% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 8.84M
- Shares sold short
- Change
- +1.69M
- +23.7% vs. previous
- Days to cover
- 11.28
- At average daily volume
Superinvestors holding ZLAB, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding ZLAB at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Zai Lab Ltd insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 (view filing)4:16 PM ET | Aug 19 | 2 days | Chen YajingChief Financial Officer | SSaleAmerican Depositary Shares | −260 | $27.00 | −$7.02K | −0.7%35.6K after | 10b5-1 |
| Aug 13, 2026 (view filing)4:15 PM ET | Aug 12 | 1 day | Lis WilliamDirector | SSaleAmerican Depositary Shares | −8.51K | $25.00 | −$212.7K | −16.9%41.9K after | 10b5-1 |
| Aug 13, 2026 (view filing)4:15 PM ET | Aug 11 | 2 days | Chen YajingChief Financial Officer | SSaleAmerican Depositary Shares | −619 | $25.00 | −$15.5K | −1.7%35.1K after | 10b5-1 |
| Jul 6, 2026 (view filing)4:14 PM ET | Jul 1 | 5 days | Gaynor RichardDirector | PPurchaseAmerican Depositary Shares | +1.74K | $19.05 | +$33.1K | +2.2%80.7K after | 10b5-1 |
| Jul 1, 2026 (view filing)4:24 PM ET | Jun 30 | 1 day | Du YingChairperson & CEO | SSaleAmerican Depositary Shares | −7.03K | $18.53 | −$130.2K | −0.6%1.20M after | |
| Jun 29, 2026 (view filing) | Jun 26 | 3 days | Edmondson Frazor Titus IIIChief Legal Officer | SSaleAmerican Depositary Shares | −4.10K | $17.46 | −$71.6K | −11.9%30.3K after | |
| Jun 29, 2026 (view filing) | Jun 26 | 3 days | Du YingChairperson & CEO | SSaleAmerican Depositary Shares | −24.5K | $17.46 | −$428.5K | −2.0%1.19M after | |
| Jun 29, 2026 (view filing) | Jun 26 | 3 days | Chen YajingChief Financial Officer | SSaleAmerican Depositary Shares | −2.26K | $17.46 | −$39.5K | −6.0%35.7K after | |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Lis WilliamDirector | SSaleAmerican Depositary Shares | −7.04K | $18.09 | −$127.4K | −12.2%50.4K after | 10b5-1 |
| May 19, 2026 (view filing) | May 15-18 | 4 days | Du YingChairperson & CEO | SSaleAmerican Depositary Shares | −100.0K | $19.87 | −$1.99M | −8.2%1.12M after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 92 holdersThe largest institutional positions in Zai Lab Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 6,574,032 | $124.9M | 1.07% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 6,137,627 | $116.6M | 2.80% | +6,137,627 | New |
| Ra Capital Management, L.P. | 5,743,533 | $109.1M | 0.95% | +36,271+0.6% | Added |
| ADAR1 Capital Management, LLC | 3,369,034 | $64.0M | 3.01% | +1,943,667+136.4% | Added |
| FMR LLC | 2,815,214 | $53.5M | 0.00% | +1,552,823+123.0% | Added |
| Goldman Sachs Group Inc | 2,315,480 | $44.0M | 0.00% | +2,204,893+1,993.8% | Added |
| Woodline Partners LP | 2,207,293 | $41.9M | 0.13% | +2,207,293 | New |
| Frazier Life Sciences Management, L.P. | 1,902,320 | $36.1M | 0.79% | 00.0% | Unchanged |
| Bamco Inc | 1,623,694 | $30.9M | 0.05% | −34,624−2.1% | Reduced |
| Two Sigma Investments, LP | 1,299,394 | $24.7M | 0.02% | +989,671+319.5% | Added |
Holders of 5% or more of ZLAB
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Zai Lab Ltd.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| RTW Investments, LP | 13G | 6.30%69.6M shares | +4.20 ppfrom 2.10% | Aug 14, 20253 filings | Feb 17, 2026 | SEC |
| Qiming Venture Partners IV, L.P. | 13G/A | 5.97%66.3M shares | – | Feb 14, 20223 filings | Aug 12, 2025 | SEC |
| TCG Crossover GP II, LLC | 13G | 5.30%59.1M shares | New | Jun 11, 20261 filing | Jun 11, 2026 | SEC |
| Ra Capital Management, L.P. | 13G | 5.20%57.4M shares | New | Apr 6, 20261 filing | Apr 6, 2026 | SEC |